(MDB) MongoDB - Overview
Sector: Technology | Industry: Software - Infrastructure | Exchange: NASDAQ (USA) | Market Cap: 20.680m USD | Total Return: 72.4% in 12m
Industry Rotation: +0.1
Avg Turnover: 357M USD
Peers RS (IBD): 55.3
EPS Trend: 57.5%
Qual. Beats: 14
Rev. Trend: 98.9%
Qual. Beats: 16
Warnings
High Debt/EBITDA (128.8) with thin interest coverage (-10.0)
Interest Coverage Ratio -10.0 is critical
Altman Z'' 0.04 < 1.0 - financial distress zone
Volatile
Tailwinds
Pead
MongoDB, Inc. (MDB) offers a general-purpose database platform globally. Its core products include MongoDB Atlas, a multi-cloud database-as-a-service (DBaaS) solution, and MongoDB Enterprise Advanced, a commercial database server for various deployment environments. The company also provides a free version, Community Server, for developers. MongoDB operates within the Internet Services & Infrastructure sector, a growth area driven by increasing data generation and cloud adoption. The companys business model relies on a freemium approach, offering a free product to attract users and then converting them to paid enterprise solutions and cloud services.
For deeper analysis, consider exploring ValueRays comprehensive data on MDBs financials and market performance.
- MongoDB Atlas subscription growth drives revenue
- Enterprise Advanced adoption expands market share
- Cloud infrastructure costs impact profitability
- Competition from established database vendors intensifies
- Global IT spending trends influence demand
| Net Income: -71.2m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.14 > 0.02 and ΔFCF/TA 10.01 > 1.0 |
| NWC/Revenue: 99.25% < 20% (prev 117.7%; Δ -18.45% < -1%) |
| CFO/TA 0.14 > 3% & CFO 513.5m > Net Income -71.2m |
| Net Debt/EBITDA: error (EBITDA <= 0) |
| Current Ratio: 4.65 > 1.5 & < 3 |
| Outstanding Shares: last quarter (86.5m) vs 12m ago 2.20% < -2% |
| Gross Margin: 71.75% > 18% (prev 0.73%; Δ 7.10k% > 0.5%) |
| Asset Turnover: 68.54% > 50% (prev 58.49%; Δ 10.05% > 0%) |
| Interest Coverage Ratio: -10.05 > 6 (EBITDA TTM -18.3m / Interest Expense TTM 5.29m) |
| A: 0.65 (Total Current Assets 3.11b - Total Current Liabilities 669.5m) / Total Assets 3.76b |
| B: -0.51 (Retained Earnings -1.91b / Total Assets 3.76b) |
| C: -0.01 (EBIT TTM -53.2m / Avg Total Assets 3.59b) |
| D: -2.35 (Book Value of Equity -1.90b / Total Liabilities 806.5m) |
| Altman-Z'' Score: 0.04 = B |
| DSRI: 1.03 (Receivables 499.0m/393.1m, Revenue 2.46b/2.01b) |
| GMI: 1.02 (GM 71.75% / 73.19%) |
| AQI: 1.23 (AQ_t 0.15 / AQ_t-1 0.12) |
| SGI: 1.23 (Revenue 2.46b / 2.01b) |
| TATA: -0.16 (NI -71.2m - CFO 513.5m) / TA 3.76b) |
| Beneish M-Score: -2.84 (Cap -4..+1) = A |
Over the past week, the price has changed by +3.80%, over one month by -6.50%, over three months by -42.33% and over the past year by +72.40%.
- StrongBuy: 19
- Buy: 9
- Hold: 12
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 354.4 | 39.5% |
P/S = 8.3936
P/B = 6.8905
P/EG = 1.6716
Revenue TTM = 2.46b USD
EBIT TTM = -53.2m USD
EBITDA TTM = -18.3m USD
Long Term Debt = 32.9m USD (from capitalLeaseObligations, last quarter)
Short Term Debt = 9.26m USD (from shortTermDebt, last quarter)
Debt = 32.9m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -2.35b USD (recalculated: Debt 32.9m - CCE 2.39b)
Enterprise Value = 18.33b USD (20.68b + Debt 32.9m - CCE 2.39b)
Interest Coverage Ratio = -10.05 (Ebit TTM -53.2m / Interest Expense TTM 5.29m)
EV/FCF = 36.04x (Enterprise Value 18.33b / FCF TTM 508.5m)
FCF Yield = 2.77% (FCF TTM 508.5m / Enterprise Value 18.33b)
FCF Margin = 20.64% (FCF TTM 508.5m / Revenue TTM 2.46b)
Net Margin = -2.89% (Net Income TTM -71.2m / Revenue TTM 2.46b)
Gross Margin = 71.75% ((Revenue TTM 2.46b - Cost of Revenue TTM 696.1m) / Revenue TTM)
Gross Margin QoQ = 73.04% (prev 71.48%)
Tobins Q-Ratio = 4.88 (Enterprise Value 18.33b / Total Assets 3.76b)
Interest Expense / Debt = 0.65% (Interest Expense 212k / Debt 32.9m)
Taxrate = 19.96% (3.87m / 19.4m)
NOPAT = -42.5m (EBIT -53.2m * (1 - 19.96%)) [loss with tax shield]
Current Ratio = 4.65 (Total Current Assets 3.11b / Total Current Liabilities 669.5m)
Debt / Equity = 0.01 (Debt 32.9m / totalStockholderEquity, last quarter 2.95b)
Debt / EBITDA = 128.8 (negative EBITDA) (Net Debt -2.35b / EBITDA -18.3m)
Debt / FCF = -4.63 (Net Debt -2.35b / FCF TTM 508.5m)
Total Stockholder Equity = 2.95b (last 4 quarters mean from totalStockholderEquity)
RoA = -1.98% (Net Income -71.2m / Total Assets 3.76b)
RoE = -2.41% (Net Income TTM -71.2m / Total Stockholder Equity 2.95b)
RoCE = -1.78% (EBIT -53.2m / Capital Employed (Equity 2.95b + L.T.Debt 32.9m))
RoIC = -1.44% (negative operating profit) (NOPAT -42.5m / Invested Capital 2.95b)
WACC = 12.50% (E(20.68b)/V(20.71b) * Re(12.52%) + D(32.9m)/V(20.71b) * Rd(0.65%) * (1-Tc(0.20)))
Discount Rate = 12.52% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 8.08%
[DCF] Terminal Value 68.31% ; FCFF base≈353.4m ; Y1≈435.9m ; Y5≈743.7m
[DCF] Fair Price = 110.8 (EV 6.55b - Net Debt -2.35b = Equity 8.90b / Shares 80.4m; r=12.50% [WACC]; 5y FCF grow 25.0% → 3.0% )
EPS Correlation: 57.55 | EPS CAGR: -2.77% | SUE: 1.35 | # QB: 14
Revenue Correlation: 98.88 | Revenue CAGR: 26.78% | SUE: 2.61 | # QB: 16
EPS next Quarter (2026-07-31): EPS=1.28 | Chg7d=+0.000 | Chg30d=+0.001 | Revisions Net=+6 | Analysts=34
EPS current Year (2027-01-31): EPS=5.83 | Chg7d=+0.000 | Chg30d=+0.010 | Revisions Net=+29 | Growth EPS=+17.3% | Growth Revenue=+17.5%
EPS next Year (2028-01-31): EPS=7.05 | Chg7d=+0.000 | Chg30d=+0.034 | Revisions Net=+8 | Growth EPS=+20.8% | Growth Revenue=+17.2%
[Analyst] Revisions Ratio: +0.23 (16 Up / 10 Down within 30d for Next Quarter)